Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asthma
asthma
RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold
Morningstar
Tue, 02/20/24 - 11:17 am
RAPT Therapeutics
clinical trials
FDA
zelnecirnon
asthma
atopic dermatits
Discontinued GSK asthma drug stirs frustrations
Beckers Hospital Review
Wed, 02/14/24 - 06:36 pm
GSK
asthma
Flovent
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals
Fierce Biotech
Tue, 12/12/23 - 11:21 am
Connect Biopharma
asthma
clinical trials
rademikibart
Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med
Fierce Biotech
Tue, 10/24/23 - 09:48 am
Aiolos Bio
funding
asthma
severe asthma
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal
Fierce Biotech
Wed, 06/21/23 - 10:54 am
AstraZeneca
Pieris
clinical trials
asthma
elarekibep
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
AstraZeneca
Amgen
Tezspire
UK
NICE
asthma
severe asthma
Dupixent kicks off 2023 as top pharma brand for ad impressions
Medical Devices and Diagnostics Industry
Mon, 02/6/23 - 06:13 pm
Sanofi
Dupixent
asthma
pharma advertising
AstraZeneca and Avillion win approval for new asthma rescue treatment in adults
Endpoints
Wed, 01/11/23 - 10:53 am
AstraZeneca
Avillion
Airsupra
asthma
FDA
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool
Tue, 12/20/22 - 10:44 am
AstraZeneca
asthma
PT027
Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication
Fierce Biotech
Wed, 11/9/22 - 10:43 am
AstraZeneca
asthma
PT027
FDA
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
asthma
severe asthma
Sanofi
Regeneron
pharma marketing
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
Wed, 10/5/22 - 10:35 am
pharma marketing
DTC advertising
AstraZeneca
eosinophilic asthma
asthma
Fasenra
Sanofi’s asthma therapy shows consistent safety profile in Phase III trial
Clinical Trials Arena
Tue, 09/6/22 - 05:06 pm
Sanofi
Dupixent
pediatric
clinical trials
severe asthma
asthma
Moving Away from Asthma and COPD, Novartis Hones in on 20 Approvals by 2026
BioSpace
Thu, 07/21/22 - 10:24 am
Novartis
asthma
COPD
Transpire Bio signs with Recipharm for inhaled medicine development
European Pharmaceutical Review
Tue, 07/19/22 - 10:38 am
Transpire Bio
Recipharm
asthma
COPD
inhaled drugs
drug development
Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review
Fierce Biotech
Tue, 07/19/22 - 10:36 am
Novartis
asthma
NASH
Retinitis pigmentosa
Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma
MedCity News
Tue, 07/12/22 - 11:29 pm
Areteia Therapeutics
ALS
asthma
eosinophilic asthma
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
BioSpace
Thu, 06/2/22 - 10:35 am
Upstream Bio
funding
asthma
allergies
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »